儿童1型糖尿病HbA1c目标演变:依据与支持证据
本文基于美国糖尿病协会2020年诊疗标准,回顾儿童1型糖尿病HbA1c目标的演变,强调个体化。多数儿童目标为<7%,特定人群可放宽至<7.5%或<8%,蜜月期可<6.5%。证据显示高血糖损害脑结构与认知、增加并发症和死亡风险,严重低血糖风险随时间下降。
要点
- 多数1型糖尿病儿童HbA1c目标为<7%,强调个体化。
- 无法识别低血糖或使用非类似物胰岛素者目标可放宽至<7.5%。
- 有严重低血糖史或严重共病者目标可放宽至<8%。
核心结论
- 美国糖尿病协会2020年标准推荐多数1型糖尿病儿童HbA1c目标为<7%(53 mmol/mol),并强调目标个体化。
研究设计与样本
- 本文为综述,基于美国糖尿病协会2020年诊疗标准及支持证据,回顾儿科HbA1c目标历史并汇总相关研究。
主要发现
- 高血糖与儿童和青少年脑结构和神经认知异常、微血管和大血管并发症、长期影响及死亡率增加相关。
- 1型糖尿病青少年总体严重低血糖风险随时间下降,部分与新型胰岛素和装置使用相关,且较低HbA1c与严重低血糖风险的关联减弱。
关键数值与推荐
- 多数1型糖尿病儿童HbA1c目标为<7%(53 mmol/mol)。
- 无法表达低血糖症状或存在低血糖无感知、无法获取类似物胰岛素或先进技术、或不能规律监测血糖的青少年,HbA1c目标<7.5%可能更合适。
- 有严重低血糖史、严重共病或预期寿命短的儿童,可考虑更宽松的HbA1c目标(如<8%)。
- 蜜月期或可实现较低平均血糖且不增加过度低血糖或降低生活质量时,HbA1c<6.5%可能安全有效。
临床怎么用
- 临床应根据儿童是否可识别低血糖、是否使用类似物胰岛素或先进技术、血糖监测能力及共病情况个体化设定HbA1c目标。
- 对无法规律监测血糖或使用非类似物胰岛素者,可考虑较宽松的HbA1c目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The American Diabetes Association 2020 Standards of Medical Care in Diabetes (Standards of Care) recommends a hemoglobin A1c (A1C) of <7% (53 mmol/mol) for many children with type 1 diabetes (T1D), with an emphasis on target personalization. A higher A1C target of <7.5% may be more suitable for youth who cannot articulate symptoms of hypoglycemia or have hypoglycemia unawareness and for those who do not have access to analog insulins or advanced diabetes technologies or who cannot monitor blood glucose regularly. Even less stringent A1C targets (e.g., <8%) may be warranted for children with a history of severe hypoglycemia, severe morbidities, or short life expectancy. During the "honeymoon" period and in situations where lower mean glycemia is achievable without excessive hypoglycemia or reduced quality of life, an A1C <6.5% may be safe and effective. Here, we provide a historical perspective of A1C targets in pediatrics and highlight evidence demonstrating detrimental effects of hyperglycemia in children and adolescents, including increased likelihood of brain structure and neurocognitive abnormalities, microvascular and macrovascular complications, long-term effects, and increased mortality. We also review data supporting a decrease over time in overall severe hypoglycemia risk for youth with T1D, partly associated with the use of newer insulins and devices, and weakened association between lower A1C and severe hypoglycemia risk. We present common barriers to achieving glycemic targets in pediatric diabetes and discuss some strategies to address them. We aim to raise awareness within the community on Standards of Care updates that impact this crucial goal in pediatric diabetes management.
引用
- Redondo MJ, Libman I, Maahs DM, et al. The Evolution of Hemoglobin A1c Targets for Youth With Type 1 Diabetes: Rationale and Supporting Evidence. Diabetes Care. 2021. PMID: 33431422. doi:10.2337/dc20-1978
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。